- Patent Title: Antisense oligonucleotides for the treatment of Stargardt disease
-
Application No.: US16465405Application Date: 2017-12-13
-
Publication No.: US11236333B2Publication Date: 2022-02-01
- Inventor: Robert Wilhelmus Johanna Collin , Alejandro Garanto Iglesias , Franciscus Peter Maria Cremers , Silvia Albert
- Applicant: STICHTING KATHOLIEKE UNIVERSITEIT
- Applicant Address: NL Nijmegen
- Assignee: STICHTING KATHOLIEKE UNIVERSITEIT
- Current Assignee: STICHTING KATHOLIEKE UNIVERSITEIT
- Current Assignee Address: NL Nijmegen
- Agency: Volpe Koenig
- Priority: EP16203864 20161213,EP17189492 20170905
- International Application: PCT/EP2017/082627 WO 20171213
- International Announcement: WO2018/109011 WO 20180621
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12N15/113 ; A61K9/00
Abstract:
The present invention relates to the field of medicine. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Stargardt disease.
Information query
